Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective.

Dold M, Leucht S.

Evid Based Ment Health. 2014 May;17(2):33-7. doi: 10.1136/eb-2014-101813. Epub 2014 Apr 8. Review.

PMID:
24713315
2.

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

Kane JM, Leucht S, Carpenter D, Docherty JP; Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.

J Clin Psychiatry. 2003;64 Suppl 12:5-19.

3.

Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, Falkai P, Kapur S, Leucht S, Licht R, Naber D, O'Keane V, Papakostas G, Vieta E, Zohar J.

Eur Neuropsychopharmacol. 2009 Jul;19(7):520-32. doi: 10.1016/j.euroneuro.2009.04.003. Epub 2009 May 2.

PMID:
19411165
4.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

5.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

6.

Augmentation strategies in clozapine-resistant schizophrenia.

Remington G, Saha A, Chong SA, Shammi C.

CNS Drugs. 2005;19(10):843-72. Review.

PMID:
16185094
7.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
8.

Strategies for dosing and switching antipsychotics for optimal clinical management.

Buckley PF, Correll CU.

J Clin Psychiatry. 2008;69 Suppl 1:4-17. Review.

9.

Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials.

Dold M, Li C, Gillies D, Leucht S.

Eur Neuropsychopharmacol. 2013 Sep;23(9):1023-33. doi: 10.1016/j.euroneuro.2013.03.001. Epub 2013 Apr 17. Review.

PMID:
23602690
10.

Evaluation of treatment-resistant schizophrenia.

Conley RR, Buchanan RW.

Schizophr Bull. 1997;23(4):663-74. Review.

PMID:
9366002
11.

Benzodiazepines for schizophrenia.

Dold M, Li C, Tardy M, Khorsand V, Gillies D, Leucht S.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD006391. doi: 10.1002/14651858.CD006391.pub2. Review.

PMID:
23152236
12.

Treatment-resistant schizophrenia--the role of clozapine.

Meltzer HY.

Curr Med Res Opin. 1997;14(1):1-20. Review.

PMID:
9524789
13.

Guideline for the pharmacotherapy of treatment-resistant schizophrenia. Royal College of Psychiatrists of Thailand.

Disayavanish C, Srisurapanont M, Udomratn P, Disayavanish P, Kasantikul D, Netrakom P, Ngamtipwatthana T, Phornchirasilp S, Rangseekajee P, Samuthrsindh P, Sukanich P, Thiam-Kaew K, Visanuyothin T.

J Med Assoc Thai. 2000 Jun;83(6):579-89. Review.

PMID:
10932483
14.

Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.

Muscatello MR, Bruno A, De Fazio P, Segura-Garcia C, Pandolfo G, Zoccali R.

Expert Opin Pharmacother. 2014 Nov;15(16):2329-45. doi: 10.1517/14656566.2014.956082. Epub 2014 Oct 5. Review.

PMID:
25284216
15.

[Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].

Papetti F, Morel-Pingault V, Buisse V, Maziere L, Banayan M, Thauby S, Besnard T, Darcourt G, Pringuey D.

Encephale. 2007 Oct;33(5):811-8. French.

PMID:
18357853
16.

Augmentation of aripiprazole with low-dose clozapine.

Stoner SC, Dahmen MM, Berges A, Petry WM.

Pharmacotherapy. 2007 Nov;27(11):1599-602.

PMID:
17963467
17.

Clozapine versus typical neuroleptic medication for schizophrenia.

Essali A, Al-Haj Haasan N, Li C, Rathbone J.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000059. doi: 10.1002/14651858.CD000059.pub2. Review.

PMID:
19160174
18.

Clozapine versus typical neuroleptic medication for schizophrenia.

Wahlbeck K, Cheine M, Essali MA.

Cochrane Database Syst Rev. 2000;(2):CD000059. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD000059.

PMID:
10796289
19.

Managing patients with "treatment-resistant" schizophrenia.

Pantelis C, Lambert TJ.

Med J Aust. 2003 May 5;178 Suppl:S62-6. Review.

PMID:
12720525
20.

Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.

Taylor DM, Young C, Paton C.

J Clin Psychiatry. 2003 Jan;64(1):30-4.

PMID:
12590620

Supplemental Content

Support Center